Diabetes Self-Management Blog

If you’re dealing with pain in your feet, you may be interested in participating in the Rhapsody Study, designed to assess the safety and effectiveness of clonidine hydrochloride topical gel, 0.1%, for treating pain associated with diabetic neuropathy (nerve damage).

To qualify, you must be from 18 to 85 years of age, have diagnosed Type 1 or Type 2 diabetes, be healthy enough to attend study visits, be able to self-apply the study treatment (or have a caregiver willing to apply the treatment), and have chronic pain in your feet as a result of diabetes. You must also be using an acceptable method of birth control and must not be pregnant or planning to conceive.

Participants in the study will receive either an investigational gel or an inactive placebo gel (neither the participants nor the investigators will know which gel they are receiving), study-related medical exams, lab tests, and an electrocardiogram (a medical test to check for heart problems) at no cost. They will need to attend up to 10 scheduled clinic visits, participate in two scheduled phone calls, and complete a brief daily diary by phone.

For more information about the study, and to find a participating doctor near you, visit the Rhapsody Study website.

And to learn more about coping with pain from nerve damage, click here to read the article “Controlling Neuropathic Pain: Tips From an Occupational Therapist.”

This blog entry was written by Web Editor Diane Fennell.


  1. There are no comments at this time.

Post a Comment

Note: All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. Be respectful of other posters. Only post information that is correct and true to your knowledge. When referencing information that is not based on personal experience, please provide links to your sources. All commenters are considered to be nonmedical professionals unless explicitly stated otherwise. Promotion of your own or someone else's business or competing site is not allowed: Sharing links to sites that are relevant to the topic at hand is permitted, but advertising is not. Once submitted, comments cannot be modified or deleted by their authors. Comments that don't follow the guidelines above may be deleted without warning. Such actions are at the sole discretion of DiabetesSelfManagement.com. Comments are moderated Monday through Friday by the editors of DiabetesSelfManagement.com. The moderators are employees of Madavor Media, LLC., and do not report any conflicts of interest. A privacy policy setting forth our policies regarding the collection, use, and disclosure of certain information relating to you and your use of this Web site can be found here. For more information, please read our Terms and Conditions.

What We're Reading
Take Part in the Big Blue Test! (10/15/14)
Free Webinar on Detecting Health-Care Errors and Fraud (10/17/14)
Ski and Snowboard Camps for Kids With Diabetes (10/06/14)
Project Blue November (10/06/14)

Diabetic Complications
Statins May Reduce Risk of Nerve Damage, Other Diabetes Complications (09/18/14)
New Approach for Neuropathy Pain? (08/18/14)
Good Control Now = Lifetime Benefit (06/25/14)



Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.

Blood Glucose Self-Monitoring — Part 3: Smart Monitoring

10 Keys to Long-Term Weight Loss

Take Your Best Shot: Stay Up to Date on Vaccines

Complete table of contents
Subscription questions